These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

241 related articles for article (PubMed ID: 21549569)

  • 61. Diamidine activity against trypanosomes: the state of the art.
    Soeiro MN; de Castro SL; de Souza EM; Batista DG; Silva CF; Boykin DW
    Curr Mol Pharmacol; 2008 Jun; 1(2):151-61. PubMed ID: 20021429
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Development of novel drugs for human African trypanosomiasis.
    Brun R; Don R; Jacobs RT; Wang MZ; Barrett MP
    Future Microbiol; 2011 Jun; 6(6):677-91. PubMed ID: 21707314
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Computer-Aided Drug Discovery Approaches against the Tropical Infectious Diseases Malaria, Tuberculosis, Trypanosomiasis, and Leishmaniasis.
    Njogu PM; Guantai EM; Pavadai E; Chibale K
    ACS Infect Dis; 2016 Jan; 2(1):8-31. PubMed ID: 27622945
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Searching for drugs for Chagas disease, leishmaniasis and schistosomiasis: a review.
    Santos SS; de Araújo RV; Giarolla J; Seoud OE; Ferreira EI
    Int J Antimicrob Agents; 2020 Apr; 55(4):105906. PubMed ID: 31987883
    [TBL] [Abstract][Full Text] [Related]  

  • 65. A recent update on new synthetic chiral compounds with antileishmanial activity.
    Verboni M; Olivieri D; Lucarini S
    Chirality; 2022 Oct; 34(10):1279-1297. PubMed ID: 35947400
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Small molecules containing chalcogen elements (S, Se, Te) as new warhead to fight neglected tropical diseases.
    Henriquez-Figuereo A; Morán-Serradilla C; Angulo-Elizari E; Sanmartín C; Plano D
    Eur J Med Chem; 2023 Jan; 246():115002. PubMed ID: 36493616
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Current treatment and drug discovery against Leishmania spp. and Plasmodium spp.: a review.
    Cruz AK; de Toledo JS; Falade M; Terrão MC; Kamchonwongpaisan S; Kyle DE; Uthaipibull C
    Curr Drug Targets; 2009 Mar; 10(3):178-92. PubMed ID: 19275555
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Screening strategies to identify new chemical diversity for drug development to treat kinetoplastid infections.
    Don R; Ioset JR
    Parasitology; 2014 Jan; 141(1):140-6. PubMed ID: 23985066
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Old Antiprotozoal Drugs: Are They Still Viable Options for Parasitic Infections or New Options for Other Diseases?
    Cortez-Maya S; Moreno-Herrera A; Palos I; Rivera G
    Curr Med Chem; 2020; 27(32):5403-5428. PubMed ID: 31264538
    [TBL] [Abstract][Full Text] [Related]  

  • 70. The Amazing World of Peptide Engineering: the Example of Antimicrobial Peptides from Frogs and Their Analogues.
    Guimarães AB; Costa FJ; Pires OR; Fontes W; Castro MS
    Protein Pept Lett; 2016; 23(8):722-37. PubMed ID: 27262306
    [TBL] [Abstract][Full Text] [Related]  

  • 71. The potential of secondary metabolites from plants as drugs or leads against protozoan neglected diseases - part I.
    Schmidt TJ; Khalid SA; Romanha AJ; Alves TM; Biavatti MW; Brun R; Da Costa FB; de Castro SL; Ferreira VF; de Lacerda MV; Lago JH; Leon LL; Lopes NP; das Neves Amorim RC; Niehues M; Ogungbe IV; Pohlit AM; Scotti MT; Setzer WN; de N C Soeiro M; Steindel M; Tempone AG
    Curr Med Chem; 2012; 19(14):2128-75. PubMed ID: 22414103
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Search for Antiprotozoal Activity in Herbal Medicinal Preparations; New Natural Leads against Neglected Tropical Diseases.
    Llurba Montesino N; Kaiser M; Brun R; Schmidt TJ
    Molecules; 2015 Aug; 20(8):14118-38. PubMed ID: 26248069
    [TBL] [Abstract][Full Text] [Related]  

  • 73. New bicyclic amines: synthesis and SARs of their action against the causative organisms of malaria and sleeping sickness.
    Weis R; Seebacher W
    Curr Med Chem; 2009; 16(11):1426-41. PubMed ID: 19355897
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Initiative launched to develop drugs for neglected diseases.
    Frankish H
    Lancet; 2003 Jul; 362(9378):135. PubMed ID: 12870480
    [No Abstract]   [Full Text] [Related]  

  • 75. Microorganisms as a Potential Source of Molecules to Control Trypanosomatid Diseases.
    Chan-Bacab MJ; Reyes-Estebanez MM; Camacho-Chab JC; Ortega-Morales BO
    Molecules; 2021 Mar; 26(5):. PubMed ID: 33806654
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Natural products as trypanocidal, antileishmanial and antimalarial drugs.
    Fournet A; Muñoz V
    Curr Top Med Chem; 2002 Nov; 2(11):1215-37. PubMed ID: 12171582
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Major parasitic infections: a global review. Parasitic Diseases Programme. World Health Organization, Geneva.
    World Health Stat Q; 1986; 39(2):145-60. PubMed ID: 2944290
    [No Abstract]   [Full Text] [Related]  

  • 78. Organometallic compounds in the discovery of new agents against kinetoplastid-caused diseases.
    Ravera M; Moreno-Viguri E; Paucar R; Pérez-Silanes S; Gabano E
    Eur J Med Chem; 2018 Jul; 155():459-482. PubMed ID: 29908440
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Gastrointestinal parasites: Part I. Protozoal infections.
    Verm RA
    Am Fam Physician; 1982 Apr; 25(4):170-5. PubMed ID: 6801941
    [No Abstract]   [Full Text] [Related]  

  • 80. Biological evaluation and structure-activity relationships of imidazole-based compounds as antiprotozoal agents.
    Saccoliti F; Madia VN; Tudino V; De Leo A; Pescatori L; Messore A; De Vita D; Scipione L; Brun R; Kaiser M; Mäser P; Calvet CM; Jennings GK; Podust LM; Costi R; Di Santo R
    Eur J Med Chem; 2018 Aug; 156():53-60. PubMed ID: 30006174
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.